Dexcom (NSDQ:DXCM) said this week that it acquired TypeZero Technologies and its personalized diabetes management solutions. The financial details of the transaction were not disclosed.
Dexcom plans to support the first commercial launch of an automated insulin delivery system using TypeZero’s inControl algorithm next year.
Get the full story at our sister site, Drug Delivery Business News.
The post Dexcom acquires diabetes management tech with TypeZero purchase appeared first on MassDevice.